CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-10 | KIES PETER CFO | Shares withheld for taxes | −6,899 | $4.51 | $31K | 82,088 |
| 2018-03-10 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −20,434 | 40,866 | ||
| 2018-03-10 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +20,434 | 129,139 | ||
| 2018-03-10 | Sardesai Niranjan Chief Operating Officer | Shares withheld for taxes | −5,653 | $4.51 | $25K | 123,486 |
| 2018-03-10 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Restricted Stock Unit | −20,434 | 40,866 | ||
| 2018-03-10 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +105,700 | 2,321,911 | ||
| 2018-03-10 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −30,104 | $4.51 | $136K | 2,291,807 |
| 2018-03-10 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −105,700 | 211,400 | ||
| 2018-03-10 | Weiner David B. Director | Exercise or conversion | +11,667 | 767,956 | ||
| 2018-03-10 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −11,667 | 23,333 | ||
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +25,000 | 73,628 | ||
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −6,896 | $4.51 | $31K | 66,732 |
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 25,000 | ||
| 2018-03-09 | KIES PETER CFO | Exercise or conversion | +25,000 | 76,974 | ||
| 2018-03-09 | KIES PETER CFO | Shares withheld for taxes | −8,421 | $4.51 | $38K | 68,553 |
| 2018-03-09 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −25,000 | 25,000 | ||
| 2018-03-09 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +25,000 | 115,601 | ||
| 2018-03-09 | Sardesai Niranjan Chief Operating Officer | Shares withheld for taxes | −6,896 | $4.51 | $31K | 108,705 |
| 2018-03-09 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 25,000 | ||
| 2018-03-09 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +57,333 | 2,232,155 |
Page 41 of 49 · 961 trades